<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1520078</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1520078</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Nanoparticle accumulation and penetration in 3D tumor models: the effect of size, shape, and surface charge</article-title>
<alt-title alt-title-type="left-running-head">Cybulski et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1520078">10.3389/fcell.2024.1520078</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cybulski</surname>
<given-names>Pierre</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2755907/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bravo</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2920163/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jim Jui-Kai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2921647/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Zundert</surname>
<given-names>Indra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2920126/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krzyzowska</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2920152/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taemaitree</surname>
<given-names>Farsai</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2924132/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uji-i</surname>
<given-names>Hiroshi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hofkens</surname>
<given-names>Johan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rocha</surname>
<given-names>Susana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/846825/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fortuni</surname>
<given-names>Beatrice</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/970834/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Molecular Imaging and Photonics</institution>, <institution>Department of Chemistry</institution>, <institution>KU Leuven</institution>, <addr-line>Leuven</addr-line>, <country>Belgium</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>ARC Centre of Excellence in Exciton Science</institution>, <institution>School of Chemistry University of Melbourne</institution>, <addr-line>Parkville</addr-line>, <addr-line>VIC</addr-line>, <country>Australia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Research Institute for Electronic Science</institution>, <institution>Hokkaido University</institution>, <addr-line>Sapporo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Institute for Integrated Cell-Material Science (WPI-iCeMS)</institution>, <institution>Kyoto University</institution>, <addr-line>Kyoto</addr-line>, <country>Japan</country>
</aff> <aff id="aff5">
<sup>5</sup>
<institution>Max Planck Institute for Polymer Research</institution>, <addr-line>Mainz</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1553630/overview">Jeremy C. Simpson</ext-link>, University College Dublin, Ireland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/82725/overview">Udayan Bhattacharya</ext-link>, Weill Cornell Medical Center, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1195711/overview">Hani Alotaibi</ext-link>, Dokuz Eyl&#xfc;l University, T&#xfc;rkiye</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Susana Rocha, <email>susana.rocha@kuleuven.be</email>; Beatrice Fortuni, <email>beatrice.fortuni@kuleuven.be</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1520078</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Cybulski, Bravo, Chen, Van Zundert, Krzyzowska, Taemaitree, Uji-i, Hofkens, Rocha and Fortuni.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Cybulski, Bravo, Chen, Van Zundert, Krzyzowska, Taemaitree, Uji-i, Hofkens, Rocha and Fortuni</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Preclinical studies have demonstrated that nanoparticles (NPs) hold significant potential for advancing cancer therapy by enhancing therapeutic efficacy while reducing side effects. Their effectiveness in solid tumors is, however, often constrained by insufficient accumulation and penetration. Understanding how the physicochemical properties of NPs &#x2013; such as size, shape, and surface charge &#x2013; influence their interaction with cells within the tumor is critical for optimizing NP design. In this study, we addressed the challenge of inconsistent NP behavior by systematically evaluating NP uptake in both 2D and 3D tumor models, and NP penetration in spheroids. Our results showed that larger NPs exhibited higher internalization rates in 2D models but limited penetration in 3D spheroids. Furthermore, negatively charged NPs consistently achieved superior accumulation and deeper penetration than neutral and positively charged NPs. Spherical NPs outperformed rod-shaped NPs in tumor accumulation and penetration. These findings underscore the importance of carefully tailoring NP properties to the complex tumor microenvironment for improved therapeutic outcomes in real tumors.</p>
</abstract>
<kwd-group>
<kwd>nanoparticles</kwd>
<kwd>3D cell models</kwd>
<kwd>tumor penetration and accumulation</kwd>
<kwd>nanoparticle uptake</kwd>
<kwd>nanoparticle size</kwd>
<kwd>nanoparticle shape</kwd>
<kwd>nanoparticle surface charge</kwd>
<kwd>spheroid models</kwd>
</kwd-group>
<contract-num rid="cn001">860914</contract-num>
<contract-num rid="cn002">G0D4519N G081916N VS08523N G0C1821N G022724N 12X1419N 12X1423N 12A6N25N</contract-num>
<contract-num rid="cn003">IDN/20/021 C14/15/053 C14/19/079 C14/22/085 GPUM/21/025</contract-num>
<contract-sponsor id="cn001">H2020 Marie Sk&#x142;odowska-Curie Actions<named-content content-type="fundref-id">10.13039/100010665</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Fonds Wetenschappelijk Onderzoek<named-content content-type="fundref-id">10.13039/501100003130</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">KU Leuven<named-content content-type="fundref-id">10.13039/501100004040</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cancer Cell Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>In recent decades, cancer research has increasingly prioritized developing more efficient and less invasive treatments, as cancer remains a leading cause of death worldwide (<xref ref-type="bibr" rid="B37">WHO, 2022</xref>). Nanoparticle (NP)-based therapies have emerged as a promising approach, offering improved tumor targeting and accumulation while reducing side effects (<xref ref-type="bibr" rid="B40">Yetisgin et al., 2020</xref>). However, despite extensive research and numerous studies demonstrating their efficacy in cancer cells and animal models, clinical adoption remains limited. By 2023, only 14 cancer nanomedicines had been approved by the Food and Drug Administration (FDA), despite more than 25,000 publications on the topic (<xref ref-type="bibr" rid="B10">Fan et al., 2023</xref>; <xref ref-type="bibr" rid="B14">He et al., 2019</xref>). This disparity underscores the challenges in translating NP-based therapies from the lab to the clinical practice.</p>
<p>Preclinical testing is predominantly based on 2D cell models, which often fail to predict <italic>in vivo</italic> outcomes (<xref ref-type="bibr" rid="B5">Biju et al., 2023</xref>). Results from 2D studies are generally not reproducible <italic>in vivo</italic> due to significant biological differences between cell monolayers and animal models (<xref ref-type="bibr" rid="B34">Van Zundert et al., 2020</xref>). One key difference is the absence of the extracellular matrix (ECM) in 2D cultures - a critical component of the tumor microenvironment. The dense and complex structure of ECM, with high fluid pressure and low pH, can hinder NP accumulation and penetration, reducing therapeutic efficacy (<xref ref-type="bibr" rid="B4">Behzadi et al., 2017</xref>; <xref ref-type="bibr" rid="B6">Bravo et al., 2024</xref>). To address these issues, more biologically relevant 3D cell models, such as multicellular tumor spheroids, have been introduced for testing nanomedicines (<xref ref-type="bibr" rid="B34">Van Zundert et al., 2020</xref>).</p>
<p>A key challenge in improving NP-based therapies efficacy in solid tumors is understanding how physicochemical properties, such as size, shape, and surface charge, influence their cellular uptake and tumor penetration (<xref ref-type="bibr" rid="B23">Lunnoo et al., 2019</xref>). Although these properties have been extensively studied in 2D cell monolayers (<xref ref-type="bibr" rid="B29">Salatin et al., 2015</xref>; <xref ref-type="bibr" rid="B24">Ma et al., 2013</xref>), research using 3D models like tumor spheroids remains limited and often inconsistent. Identifying the optimal NP properties for better penetration and accumulation in 3D models is crucial to boost clinical translatability of NP-based therapies.</p>
<p>A few studies have explored the optimal NP size for deeper spheroid penetration across a range of sizes. Huang&#x2019;s work revealed that 2&#xa0;nm NPs accumulated and penetrated more effectively than 6&#xa0;nm and 15&#xa0;nm particles (<xref ref-type="bibr" rid="B17">Huang et al., 2012</xref>). Pratiwi and Tchoryk reported that NPs in the 25&#x2013;50&#xa0;nm range exhibited similar accumulation and penetration, outperforming larger 100&#x2013;200&#xa0;nm NPs (<xref ref-type="bibr" rid="B28">Pratiwi et al., 2021</xref>; <xref ref-type="bibr" rid="B33">Tchoryk et al., 2019</xref>). On the other hand, Agarwal observed no significant difference in accumulation or penetration between 100, 200, and 500&#xa0;nm spheres (<xref ref-type="bibr" rid="B1">Agarwal et al., 2015</xref>). Collectively, these reports suggest smaller NPs tend to achieve deeper penetration in 3D spheroids, though the ideal size remains unclear. The effect of surface charge adds further complexity, with studies often presenting contradictory results. For instance, Wang et al. reported enhanced penetration for positively charged NPs in both 3D spheroids and <italic>in vivo</italic> tumors (<xref ref-type="bibr" rid="B36">Wang et al., 2016</xref>), while Sujai et al., in a later study, found that negative gold NPs (AuNPs) accumulated more and penetrated deeper in similar models (<xref ref-type="bibr" rid="B32">Sujai et al., 2020</xref>). Expanding these challenges, the few studies on NP shape report conflicting results. Zhang et al. showed that elongated NPs, such as nanorods, penetrated spheroids more effectively than spherical ones (<xref ref-type="bibr" rid="B41">Zhang et al., 2019</xref>), while Zhao et al. observed better penetration depth with spherical NPs over rods (<xref ref-type="bibr" rid="B42">Zhao et al., 2017</xref>). The inconsistencies underscore the challenges in defining optimal NP properties, highlighting the need for a systematic approach to understand how size, charge, and shape influence the behavior of NPs both in 2D and in 3D environments.</p>
<p>This study aims to shed light on the impact of size, surface charge, and shape on NP behavior, in 2D cell monolayers and 3D spheroids. A major challenge in such comparative studies is to isolate the impact of each parameter while keeping others constant. For this purpose, AuNPs of different sizes, shapes, and surface charges were incubated with A549 lung carcinoma cells, chosen for their ability to form compact, tumor-like spheroids, closely mimicking solid tumors. Confocal fluorescence microscopy was used to monitor NP internalization in 2D models, and NP accumulation and penetration in 3D models. AuNPs were chosen as a model due to their highly tunable size, shape and surface chemistry (<xref ref-type="bibr" rid="B9">Dreaden et al., 2012</xref>). Moreover, their intrinsic photoluminescence (PL) allows for precise and fluorophore-free imaging under two-photon excitation (<xref ref-type="bibr" rid="B27">Olesiak-Banska et al., 2019</xref>). To accurately assess the penetration of each NP type in 3D models, we used an in-house developed algorithm for analysis of the fluorescence images acquired.</p>
<p>These findings will be valuable for optimizing NP designs that better address the complexities of tumor microenvironments, potentially enhancing the efficacy of NP-based therapies. By understanding how specific NP properties impact accumulation and penetration, this study lays the groundwork for tailoring NP features to achieve improved therapeutic outcomes.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Materials</title>
<p>AuNPs were acquired from Nanopartz Inc, with part numbers A11-15-CIT-DIH-1-25 (AuNS10), A11-35-CIT-DIH-1-25 (AuNS30), A11-55-CIT-DIH-1-25 (AuNS50), A11-75-CIT-DIH-1-25 (AuNS65), CC12-10-750-NEG-DIH-50&#x2013;1 [AuNR(&#x2212;)], 10&#x2013;750-ZERO-DIH-50&#x2013;1 [(AuNR&#xd8;)], and 10&#x2013;750-POS-DIH-50&#x2013;1 [AuNR(&#x2b;)]. Dulbecco&#x2019;s Modified Eagle Medium (DMEM), gentamicin, phosphate buffered saline (PBS), formaldehyde, trypsin-EDTA (0.5%), Hank&#x2019;s balanced salt solution (HBSS), Triton X-100 (0.1%), CellMask&#x2122; Green and Deep Red were obtained from ThermoFisher Scientific. Fetal Bovine Serum (FBS) and Glutamax were purchased from Sigma Aldrich. Phalloidin CruzFluor&#x2122; 488 and 647 were obtained from Santa Cruz Biotechnology.</p>
</sec>
<sec id="s2-2">
<title>Cell culture</title>
<p>A549 cells were maintained in T25 culture flasks at 37&#xb0;C in a 5% CO&#x2082; atmosphere. The cells were grown in cell culture medium (DMEM supplemented with 10% FBS, 1% Glutamax, and 0.1% gentamicin), and were passaged using trypsin-EDTA when a confluency of 80%&#x2013;90% was reached.</p>
</sec>
<sec id="s2-3">
<title>Cell monolayer assays (2D)</title>
<p>A549 cells were seeded in 29&#xa0;mm glass-bottom dishes (D29-14-1.5-N, CellVis) and grown to 60% confluency. NPs were added at &#x223c;8&#xd7;10<sup>1</sup>&#x2070; NPs/mL for size and shape studies, and &#x223c;4&#xd7;10<sup>11</sup> NPs/mL for charge studies. After 3&#xa0;h of incubation, cells were washed three times with PBS, fresh culture medium was added and the samples were incubated for additional 24&#xa0;h at 37&#xb0;C. Before imaging, the samples were stained with CellMask&#x2122; Deep Red for AuNSs, or CellMask&#x2122; Green for AuNRs (1 &#x3bc;M in HBSS, 5 min), washed three times with PBS, and imaged in HBSS.</p>
</sec>
<sec id="s2-4">
<title>Spheroid assays (3D)</title>
<p>At 90% confluency, A549 cells were harvested for spheroid formation. Spheroids were formed in agarose microtissues with 256 wells (16 &#xd7; 16 array), cast from ultra-pure agarose (20&#xa0;mg/mL in Milli-Q water with 9&#xa0;mg/mL NaCl) using a 3D micro-mold (3D Petri Dish<sup>&#xae;</sup>, Sigma Aldrich). Once solidified, the microtissue was placed in a culture plate well and equilibrated with culture medium for 15&#xa0;min. A 190&#xa0;&#x3bc;L of a cell suspension (&#x223c;2.5&#xd7;10<sup>5</sup> cells) was added, allowing the cells to settle for 30&#xa0;min before adding additional culture medium around the microtissue.</p>
<p>After 4&#xa0;days of incubation, spheroids with diameters of 250&#x2013;350&#xa0;&#x3bc;m were formed and the medium surrounding the microtissues was carefully removed. 190&#xa0;&#x3bc;L of NP-containing medium was added to the wells (&#x223c;8&#xd7;10<sup>9</sup> NPs/mL for size; &#x223c;4&#xd7;10<sup>11</sup> NPs/mL for charge; &#x223c;5&#xd7;10<sup>1</sup>&#x2070; NPs/mL for shape). After 30&#xa0;min, more medium was added around the microtissues to avoid diluting the NP-containing medium inside. Spheroids were incubated with NPs for 24&#xa0;h, then the medium was removed, and 1&#xa0;mL of warm PBS was pipetted over the microtissues to dislodge spheroids, which were then collected and transferred to 1.5&#xa0;mL microcentrifuge tubes.</p>
<p>Harvested spheroids were stained as previously reported (<xref ref-type="bibr" rid="B35">Van Zundert et al., 2022</xref>). Briefly, they were washed three times with PBS, centrifuged at 2000 <italic>g</italic> for 10&#xa0;s between washes, then fixed in 500&#xa0;uL of 4% paraformaldehyde for 20&#xa0;min, followed by another three PBS washes. Permeabilization was done using 1&#xa0;mL of 0.1% Triton X-100 in PBS for 20&#xa0;min. Spheroids were then incubated with 200&#xa0;&#x3bc;L of Phalloidin CruzFluor&#x2122; 488 (AuNR) or Phalloidin CruzFluor&#x2122; 647 (AuNS) in 3% BSA at a 1:1000 dilution overnight at room temperature. The next day, spheroids were washed three times with PBS and prepared for imaging.</p>
</sec>
<sec id="s2-5">
<title>Fluorescence microscopy</title>
<p>Live-cell imaging was performed in HBSS at 37&#xb0;C and 5% CO&#x2082;, using a Leica TCS SP8 DIVE inverted microscope equipped with a &#xd7;63 oil immersion objective (NA 1.4) for 2D models and a &#xd7;25 water immersion objective (NA 0.95, FLUOTAR VISIR) for 3D models. A multiphoton InSight X3 laser (Spectra-Physics<sup>&#xae;</sup>) was used for AuNPs imaging (AuNS: 800&#xa0;nm, 3.8&#xa0;mW at the objective, 525&#x2013;575&#xa0;nm detection; AuNRs: 1300&#xa0;nm, 3.8&#xa0;mW, 655&#x2013;755&#xa0;nm detection. Diode lasers were used for the fluorescence probes used: 488&#xa0;nm diode laser for CellMask&#x2122; Green and Phalloidin CruzFluor&#x2122; 488 (detection: 491&#x2013;541&#xa0;nm); 638&#xa0;nm diode laser for CellMask&#x2122; Deep Red and Phalloidin CruzFluor&#x2122; 647 (detection: 650&#x2013;700&#xa0;nm). Sequential scanning was used to avoid crosstalk between the channels. Image stacks of 1024 &#xd7; 1024 pixels were acquired at a scanning speed of 400&#xa0;Hz, with three-line averaging and a 0.3 or 1&#xa0;&#xb5;m z-step, for 2D or 3D assays, respectively.</p>
</sec>
<sec id="s2-6">
<title>Spheroid penetration analysis</title>
<p>At least 15 spheroids per condition were analyzed using an in-house algorithm to calculate the mean NP photoluminescence (PL) intensity across penetration depth. The algorithm first plots the spheroid diameter along the <italic>z</italic>-axis, allowing the user to select the z range with the largest diameter for analysis. Each xy image in the chosen z range is segmented into 5&#xa0;&#xb5;m rings and the mean NP PL is calculated for each ring (snapshots of the software in <xref ref-type="sec" rid="s15">Supplementary Figure S13</xref>). The values from each stack were normalized (min-max) to generate a penetration curve of each spheroid and the mean penetration was calculated by averaging the normalized curves across all spheroids in each condition.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Nanoparticle characterization</title>
<p>Before testing the different AuNPs in cell models, their physicochemical properties were characterized (<xref ref-type="fig" rid="F1">Figure 1</xref>). Electron microscopy (EM) images showed that gold nanospheres (AuNSs) had a uniform spherical shape, with mean diameters of 12, 31, 49, and 64&#xa0;nm, corresponding to AuNS10, AuNS30, AuNS50, and AuNS65, respectively (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;D, F</xref>). For the charge effect investigation, gold nanorods (AuNRs) with negative, neutral, and positive surface modifications were selected and named AuNR(&#x2212;), AuNR&#xd8;, and AuNR(&#x2b;). Transmission EM confirmed their rod-shaped structure, with dimensions of &#x223c;50&#xa0;nm by &#x223c;15&#xa0;nm (<xref ref-type="fig" rid="F1">Figure 1E</xref>, size distributions in <xref ref-type="sec" rid="s15">Supplementary Figure S1C</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Nanoparticle characterization. Electron microscopy images of <bold>(A)</bold> AuNS10, <bold>(B)</bold> AuNS30, <bold>(C)</bold> AuNS50, <bold>(D)</bold> AuNS65, <bold>(E)</bold> AuNR(&#x2212;); since no differences were observed between the AuNR samples in EM images, AuNR(&#x2212;) is shown as a representative, while AuNR&#xd8; and AuNR(&#x2b;) are displayed in <xref ref-type="sec" rid="s15">Supplementary Figure S1A, B</xref>. Scale bars: 100&#xa0;nm. <bold>(F)</bold> AuNSs size distribution based on electron microscopy images. <bold>(G)</bold> Zeta potential of AuNR(&#x2212;), AuNR&#xd8;, and AuNR(&#x2b;). <bold>(H)</bold> Extinction spectra in water. <bold>(I)</bold> Summary table with values shown as mean &#xb1; standard deviation.</p>
</caption>
<graphic xlink:href="fcell-12-1520078-g001.tif"/>
</fig>
<p>For all the experiments here reported, NPs were stored as water-based colloidal solutions and small volumes of these solutions were added to the cell culture medium for NP incubation with cells. The surface charges of the different NPs were therefore estimated both in water and in cell culture medium using Zeta potential measurements. The results are summarized in <xref ref-type="fig" rid="F1">Figure 1I</xref>. In water, the Zeta potentials of AuNR(&#x2212;), AuNR&#xd8;, and AuNR(&#x2b;) were &#x2212;30 mV, &#x2212;3 mV, and 57&#xa0;mV, respectively (<xref ref-type="fig" rid="F1">Figure 1G</xref>). Zeta potentials of the different spherical NPs were consistent across the different sizes: &#x2212;41&#xa0;mV for AuNS10; &#x2212;46&#xa0;mV for AuNS30; &#x2212;48&#xa0;mV for AuNS50; and &#x2212;52&#xa0;mV for AuNS65 (<xref ref-type="sec" rid="s15">Supplementary Figure S1D</xref>). While suspension in cell medium did not significantly alter the surface charge of the AuNSs, AuNR(&#x2212;) and AuNR&#xd8;, it caused a major change in AuNR(&#x2b;), reducing the Zeta potential from 57&#xa0;mV in water to &#x2212;13&#xa0;mV (<xref ref-type="fig" rid="F1">Figure 1I</xref>).</p>
<p>The optical properties of each AuNP were characterized by measuring the localized surface plasmon resonance (LSPR) bands using UV-VIS spectroscopy (<xref ref-type="fig" rid="F1">Figure 1H</xref>). The extinction spectra of AuNS10, AuNS30, AuNS50, and AuNS65 exhibited a single plasmonic band at 516&#xa0;nm, 524&#xa0;nm, 533&#xa0;nm, and 544&#xa0;nm, respectively. A red shift of the plasmonic peak normally occurs with the increase in NP size (<xref ref-type="bibr" rid="B18">Huang and El-Sayed, 2010</xref>). In contrast, AuNRs showed two LSPR peaks - transverse and longitudinal - typical of rod-shaped AuNPs (<xref ref-type="bibr" rid="B22">Link and El-Sayed, 2005</xref>). These peaks were at 512&#xa0;nm and 741&#xa0;nm for AuNR(&#x2212;), 511&#xa0;nm and 739&#xa0;nm for AuNR&#xd8;, and 515&#xa0;nm and 769&#xa0;nm for AuNR(&#x2b;). The slight shifts in peak positions among the three AuNR samples are attributed to their different surface modifications (<xref ref-type="bibr" rid="B38">Wriedt, 2012</xref>), which account for the different surface charges.</p>
</sec>
<sec id="s3-2">
<title>Influence of NP size</title>
<p>To study the effect of NP size in 2D cell models, A549 human lung adenocarcinoma cells were cultured in 2D monolayers and incubated for 3&#xa0;h with AuNS10, AuNS30, AuNS50, and AuNS65. <xref ref-type="fig" rid="F2">Figures 2A&#x2013;D</xref> show representative xy planes from z-stacks, alongside xz and yz orthogonal views, for each NP size. AuNS10 exhibited low and heterogeneous internalization (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S2</xref>), while a significant increase in uptake was observed for AuNS30, AuNS50, and AuNS65 (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;D</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S2</xref>). Among these, AuNS65 had the highest uptake, followed by AuNS30 and AuNS50.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The effect of NP size on cellular uptake and spheroid penetration. Representative confocal fluorescence images of AuNS10, AuNS30, AuNS50, and AuNS65 in <bold>(A-D)</bold> 2D monolayers and <bold>(E-P)</bold> 3D spheroids of A549 cells. Cells were incubated with &#x223c;8&#xd7;10<sup>1</sup>&#x2070; NPs/mL for 3&#xa0;h or &#x223c;8&#xd7;10<sup>9</sup> NPs/mL for 24&#xa0;h, for 2D or 3D models, respectively. NP PL is shown in green while cellular staining appears in magenta (CellMask&#x2122; Deep Red plasma membrane staining for 2D models and Phalloidin CruzFluor&#x2122; 647 for cytoskeleton staining in 3D models). Scale bars: 50&#xa0;&#xb5;m. <bold>(A-D)</bold> xy images and orthogonal section of 2D monolayers. <bold>(E-H)</bold> Maximal intensity z-projection images of A549 spheroids <bold>(I-L),</bold> xy images and orthogonal section of 3D spheroids. <bold>(M-P)</bold> Zoomed-in xy images of the top left &#xbc; area of the spheroids shown in <bold>(I&#x2013;L)</bold> with white arrows indicating NPs. Additional images are provided in <xref ref-type="sec" rid="s15">Supplementary Figure S2</xref> (for 2D models) and <xref ref-type="sec" rid="s15">Supplementary Figure S3</xref> (for 3D models). <bold>(Q)</bold> Normalized mean PL intensity of NPs <italic>versus</italic> spheroid depth. Curves for individual spheroids are shown in <xref ref-type="sec" rid="s15">Supplementary Figure S4</xref>.</p>
</caption>
<graphic xlink:href="fcell-12-1520078-g002.tif"/>
</fig>
<p>To investigate the effect of NP size on accumulation and penetration in 3D models, A549 spheroids were incubated with the AuNSs for 24&#xa0;h. Maximum intensity z-projection images of the spheroids after incubation with different-sized AuNSs suggest a linear increase in NP accumulation with size. Only a few AuNS10 were detected within the spheroids (<xref ref-type="fig" rid="F2">Figures 2E</xref>;<xref ref-type="sec" rid="s15">Supplementary Figure S3</xref>), whereas AuNS30, AuNS50, and AuNS65 showed progressively higher levels of accumulation (<xref ref-type="fig" rid="F2">Figures 2F&#x2013;H</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S3</xref>). However, in z-projection images, where xy planes are combined across the 3D structure, NPs in the inner region cannot be differentiated from those on the surface. This distinction is instead clear in single xy planes (mid-spheroid) and orthogonal xz and yz, which show a consistent trend: almost no NPs for AuNS10 (<xref ref-type="fig" rid="F2">Figure 2I</xref>), minimal for AuNS30 (<xref ref-type="fig" rid="F2">Figure 2J</xref>), a moderate increase for AuNS50 (<xref ref-type="fig" rid="F2">Figure 2K</xref>), and a significantly higher accumulation for AuNS65 (<xref ref-type="fig" rid="F2">Figure 2L</xref>). Overall, both 2D and 3D data indicate that AuNS10 has the lowest internalization, while AuNS65 shows the highest one among the four sizes tested.</p>
<p>Magnified xy images reveal that NP size also impacts spheroid penetration (<xref ref-type="fig" rid="F2">Figures 2M-P</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S3</xref>). Despite their very low number, AuNS10 were evenly distributed between the peripherical layers and the spheroid center (<xref ref-type="fig" rid="F2">Figure 2M</xref>, white arrows) and AuNS30 were mainly located in the first two peripherical cell layers, with some penetrating slightly deeper (<xref ref-type="fig" rid="F2">Figure 2N</xref>, white arrow). In contrast, AuNS50 and AuNS65 showed limited penetration, being mostly confined to the outer layers (<xref ref-type="fig" rid="F2">Figure 2O-P</xref>).</p>
<p>To confirm these observations, the photoluminescence (PL) intensity of AuNSs across spheroid depth was analyzed using custom software. Briefly, each spheroid was divided into 5&#xa0;&#x3bc;m thick rings and the mean PL per ring was calculated (<xref ref-type="sec" rid="s15">Supplementary Figure S13</xref>). Since the amount of accumulated particles varied, the PL curves for each spheroid were normalized to highlight differences in penetration depth (<xref ref-type="fig" rid="F2">Figure 2Q</xref>). For all four NPs the PL curves decayed with penetration depth. AuNS10 showed the deepest penetration and an irregular decay, with PL intensity linearly dropping up to &#x223c;30&#xa0;&#x3bc;m from the surface and slightly increasing at 45&#xa0;&#x3bc;m, 65&#xa0;&#x3bc;m, and 85&#xa0;&#xb5;m. These variations and high standard deviation (SD) of PL values resulted from the low NP accumulation but also pointed to the presence of NPs at different depths, as shown in the fluorescence images (<xref ref-type="fig" rid="F2">Figure 2M</xref>). AuNS30, AuNS50, and AuNS65 penetration curves decayed very similarly, with the PL drastically dropping at &#x223c;30&#x2013;40&#xa0;&#xb5;m depth, corresponding to about 2&#xa0;cell layers. The AuNS30 curve had a slight increase at &#x223c;70&#xa0;&#x3bc;m, indicating the presence of some NPs in deeper layers, as shown in <xref ref-type="fig" rid="F2">Figure 2N</xref>. In summary, larger NPs accumulated more, while smaller NPs penetrated deeper into the spheroids.</p>
</sec>
<sec id="s3-3">
<title>Influence of the surface charge</title>
<p>To investigate the influence of surface charge on NP cellular uptake, A549 cell monolayers were incubated with three differently charged AuNRs for 3&#xa0;h. Confocal fluorescence images revealed charge-dependent differences in cellular uptake: AuNR(-) had the highest internalization, followed by AuNR&#xd8;, while AuNR(&#x002B;) showed minimal uptake (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S5</xref>). The internalization of AuNR&#xd8; varied among cells, with some showing NP aggregates.</p>
<p>To assess the impact of NP surface charge on accumulation and penetration in 3D models, A549 spheroids were incubated with AuNR(&#x2212;), AuNR&#xd8;, or AuNR(&#x2b;) for 24&#xa0;h. Maximum intensity z-projections of spheroids, incubated with the differently charged NPs, showed the highest accumulation for AuNR(&#x2212;), followed by AuNR(&#x2b;), where a substantial amount of NPs was still detected, and AuNR&#xd8;, with a very low number of NPs (<xref ref-type="fig" rid="F3">Figures 3D&#x2013;F</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S6</xref>). Overall, AuNR(&#x2212;) had the highest internalization in both 2D and 3D models, while for AuNR&#xd8;, which had a high uptake in 2D, very few particles were detected in 3D spheroids. The amount of internalized NPs observed in the xy images confirmed this accumulation trend (<xref ref-type="fig" rid="F3">Figures 3G&#x2013;I</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S6</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The effect of NP charge on cellular uptake and spheroid penetration. Representative confocal fluorescence images of AuNR(&#x2212;), AuNR&#xd8;, and AuNR(&#x2b;) in <bold>(A-C)</bold> 2D monolayers and <bold>(D-L)</bold> 3D spheroids of A549 cells. Cells were incubated with &#x223c;4&#xd7;10<sup>11</sup> NPs/mL for 3&#xa0;h or 24 h, for 2D or 3D models, respectively. NP PL is shown in green while cellular staining appears in magenta (CellMask&#x2122; Green plasma membrane staining for 2D models and Phalloidin CruzFluor&#x2122; 488 for cytoskeleton staining in 3D models). Scale bars: 50&#xa0;&#xb5;m. <bold>(A-C)</bold> xy images and orthogonal section of 2D monolayers. <bold>(D-F)</bold> Maximal intensity z-projection images of A549 spheroids <bold>(G-I)</bold> xy images and orthogonal section of 3D spheroids. The intensity range is adjusted for each image to highlight NP penetration. Images with the same intensity range are shown in <xref ref-type="sec" rid="s15">Supplementary Figure S7</xref>. <bold>(J-L)</bold> Zoomed-in xy images of the top left &#xbc; area of the spheroids reported in <bold>(G&#x2013;I)</bold>. Additional images are provided in <xref ref-type="sec" rid="s15">Supplementary Figure S5</xref> (for 2D models) and <xref ref-type="sec" rid="s15">Supplementary Figure S6</xref> (for 3D models). <bold>(M)</bold> Normalized mean PL intensity of NPs <italic>versus</italic> spheroid depth. Curves for individual spheroids are shown in <xref ref-type="sec" rid="s15">Supplementary Figure S7</xref>.</p>
</caption>
<graphic xlink:href="fcell-12-1520078-g003.tif"/>
</fig>
<p>Regarding penetration, magnified xy images show that most NPs, regardless of the charge, are confined to the first one or two outer cell layers of the spheroid (<xref ref-type="fig" rid="F3">Figure 3J-L</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S6</xref>). Despite a few AuNR(&#x2212;) particles being found deeper inside the spheroid (<xref ref-type="fig" rid="F3">Figure 3J</xref>, white arrows), the penetration curves revealed no significant differences between the different NPs (<xref ref-type="fig" rid="F3">Figure 3M</xref>), as these inner NPs accounted for a very small fraction of the total particles detected. In summary, negatively charged NPs showed the highest accumulation and marginally deeper penetration in 3D cell models.</p>
</sec>
<sec id="s3-4">
<title>Influence of NP shape</title>
<p>To explore the influence of the shape on NP cellular uptake, rod-shaped and spherical NPs were compared. Negatively charged NPs were selected to eliminate surface charge effects and enhance cellular uptake, as well as spheroid accumulation (<xref ref-type="fig" rid="F1">Figure 1I</xref>). A549 cell monolayers were incubated with AuNS10, AuNS50, or AuNR(&#x2212;). AuNS10 and AuNS50 were selected as spherical NPs, as their diameters matched the two dimensions of AuNR(&#x2212;).</p>
<p>
<xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref> show representative fluorescence images for the three conditions. In 2D monolayers, internalization of rod-shaped NPs was lower compared to spherical NPs, with a more significant difference observed with AuNS50 (<xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S9</xref>). The larger spherical NPs, indeed, showed the highest uptake, as expected from the size comparison experiments (<xref ref-type="fig" rid="F2">Figure 2</xref>). Of note, differences in internalization are evident between <xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">Figure 4</xref> due to the different concentrations used. For this set of experiments, the [AuNR(&#x2212;)] was reduced, whereas the [AuNSs] was increased to match concentrations across the three samples.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The effect of NP shape on cellular uptake and spheroid penetration. Representative confocal fluorescence images of AuNS10, AuNS50, and AuNR(&#x2212;) in <bold>(A-C)</bold> 2D monolayers and <bold>(D-L)</bold> 3D spheroids of A549. Cells were incubated with &#x223c;8&#xd7;10<sup>1</sup>&#x2070; NPs/mL for 3&#xa0;h or &#x223c;5&#xd7;10<sup>1</sup>&#x2070; NPs/mL for 24 h, for 2D or 3D models, respectively. NP PL is shown in green while cellular staining appears in magenta (CellMask&#x2122; Deep Red and Green plasma membrane staining for 2D models incubated with AuNSs and AuNRs, respectively, and Phalloidin CruzFluor&#x2122; 647 and 488 for cytoskeleton staining in 3D models incubated with AuNSs and AuNRs, respectively). Scale bars: 50&#xa0;&#xb5;m. <bold>(A-C)</bold> xy images and orthogonal section of 2D monolayers. <bold>(D-F)</bold> Maximal intensity z-projection images of A549 spheroids <bold>(G-I)</bold> xy images and orthogonal section of 3D spheroids. The intensity range is adjusted for each image to highlight NP penetration. Images with the same intensity range are shown in <xref ref-type="sec" rid="s15">Supplementary Figure S11</xref>. <bold>(J-L)</bold> Zoomed-in xy images of the top left &#xbc; area of the spheroids reported in <bold>(G&#x2013;I)</bold>. Additional images are provided in <xref ref-type="sec" rid="s15">Supplementary Figure S9</xref> (for 2D models) and <xref ref-type="sec" rid="s15">Supplementary Figure S10</xref> (for 3D models). <bold>(M)</bold> Normalized mean PL intensity of NPs <italic>versus</italic> spheroid depth. Curves for individual spheroids are shown in <xref ref-type="sec" rid="s15">Supplementary Figure S12</xref>.</p>
</caption>
<graphic xlink:href="fcell-12-1520078-g004.tif"/>
</fig>
<p>For the experiments in 3D models, A549 spheroids were incubated with AuNS10, AuNS50, and AuNR(&#x2212;) for 24&#xa0;h. Based on maximum intensity z-projections and single xy images, NP accumulation follows a trend consistent with the results from the 2D models: AuNR(&#x2212;) had the lowest accumulation, followed by AuNS10, while AuNS50 exhibited a significantly higher accumulation (<xref ref-type="fig" rid="F4">Figures 4D&#x2013;I</xref>; <xref ref-type="sec" rid="s15">Supplementary Figure S10</xref>). Regarding NP penetration, magnified xy images highlight that AuNS10 penetrated deeper into the spheroid (<xref ref-type="fig" rid="F4">Figure 4J</xref>, white arrows). By contrast, AuNS50 primarily accumulated in the first two to three peripherical cell layers (<xref ref-type="fig" rid="F4">Figure 4K</xref>, white arrows), with a small fraction occasionally reaching deeper, close to the spheroid core (<xref ref-type="sec" rid="s15">Supplementary Figure S10E</xref>, white arrow). AuNR(&#x2212;) remained mostly in the first 2&#xa0;cell layers (<xref ref-type="fig" rid="F4">Figure 4L</xref>, white arrows). As depicted in <xref ref-type="fig" rid="F4">Figure 4M</xref>, calculated penetration curves confirm these findings. AuNS10 penetration gradually decreased with spheroid depth reaching negligible values around 70&#xa0;&#xb5;m. The AuNS50 curve presented a sharp drop at &#x223c;30&#x2013;40&#xa0;&#xb5;m with a rise near 75&#xa0;&#x3bc;m, indicating the presence of some NPs at the spheroid core. The AuNR(&#x2212;) curve decreased rapidly at &#x223c;35&#xa0;&#xb5;m (about 2&#xa0;cell layers) and flattened beyond this depth. Overall, spherical NPs achieved the highest internalization and deeper penetration.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this systematic study, we investigated the influence of NP size, shape, and surface charge on cellular uptake in 2D monolayers, and accumulation/penetration in 3D spheroids. By isolating each NP property, we provide a comprehensive perspective on NP-cell interactions. A major strength of this work is the direct comparison of the effect of nanoparticle size, surface charge and shape across both 2D and 3D models, using the same cell line, a universal 3D model, and NPs made of the same material for consistency. While spheroids replicate key aspects of tumor physiology, including the pH and oxygen gradient observed in solid tumors (<xref ref-type="bibr" rid="B13">G&#xf6;rlach and Acker, 1994</xref>), NP behavior may differ in more complex 3D systems and <italic>in vivo</italic> environments, where factors such as cell heterogeneity, extracellular matrix (ECM) composition, and microenvironmental conditions play significant roles. This study focuses on simplified tumor models to minimize the impact of these variables and specifically investigate the intrinsic effects of NP properties. By doing so, it establishes fundamental knowledge that can serve as a foundation for future research involving more biologically complex models.</p>
</sec>
<sec id="s5">
<title>Effect of nanoparticle size</title>
<p>Our results reveal that larger NPs are generally internalized more efficiently than smaller ones. The size-dependent variation in cellular uptake can be attributed to several factors. Smaller NPs, like AuNS10, are more affected by Brownian motion, leading to increased random movement and fewer interactions with the cell membrane, thereby limiting internalization (<xref ref-type="bibr" rid="B4">Behzadi et al., 2017</xref>). In contrast, larger NPs, such as AuNS65, tend to sediment onto the cell membrane, promoting cellular uptake. Membrane wrapping during endocytosis, which is more efficient for larger NPs (<xref ref-type="bibr" rid="B15">Hoshyar et al., 2016</xref>; <xref ref-type="bibr" rid="B30">Shang et al., 2014</xref>), may also contribute to the size-dependent NP internalization. NPs between 30&#x2013;60&#xa0;nm are more effective at promoting receptor binding, which enhances membrane wrapping and endocytosis. Smaller NPs, like AuNS10, are less effective at initiating this process due to reduced receptor interactions. Despite the trend observed, AuNS50 had a lower internalization than AuNS30. This suggests possible differences in endocytic or exocytosis pathways, though the exact reason remains unclear.</p>
<p>NP behavior in 3D models is shaped by factors beyond uptake mechanisms, including ECM density and diffusion barriers. Smaller NPs like AuNS10 penetrate deeper into spheroids, likely due to increased Brownian motion, which reduces NP internalization but improves diffusion through the ECM and interstitial spaces (<xref ref-type="bibr" rid="B2">Barua and Mitragotri, 2014</xref>). Larger NPs, however, experience stronger NP-cell interactions and increased cellular uptake, but limited diffusion through the ECM, which confines them to the peripheral cell layers. In a recent study, Chen et al. observed a similar size-dependent behavior of spherical, negatively charged gold NPs in MDA-MB-231 spheroids, and attributed it to different penetration pathways. They demonstrated that, while large NPs (&#x223c;60&#xa0;nm) penetrate exclusively via energy-dependent transcytosis, smaller NPs (&#x223c;15 and &#x223c;22&#xa0;nm) can passively diffuse through the 3D cell structure via energy-independent transcellular and paracellular pathways, which enable a deeper tumor penetration (<xref ref-type="bibr" rid="B7">Chen et al., 2024</xref>).</p>
<p>These results show that while larger NPs accumulate efficiently in solid tumors, they lack the penetration depth achieved by smaller NPs. These findings highlight the need for designing the next-generation NPs with smaller sizes and bioactive surfaces to enhance internalization through targeted interactions (<xref ref-type="bibr" rid="B8">Chen et al., 2023</xref>).</p>
</sec>
<sec id="s6">
<title>Effect of surface charge</title>
<p>Our study demonstrates that negatively charged NPs exhibit the highest internalization, followed by neutral and positive NPs. Although positive NPs are generally expected to interact with the negatively charged plasma membrane (<xref ref-type="bibr" rid="B25">Ma et al., 2017</xref>), enhancing NP internalization (<xref ref-type="bibr" rid="B31">Shin et al., 2013</xref>), AuNR(&#x2b;) showed the lowest uptake in 2D monolayers. This unexpected contradiction can be explained by the change of the surface charge of AuNR(&#x2b;) in cell culture medium, as indicated by a drop in the Zeta potential (from 57 to &#x2212;13 mV, <xref ref-type="fig" rid="F1">Figure 1I</xref>). In the medium, a protein corona, mainly composed of negatively charged proteins like albumin (<xref ref-type="bibr" rid="B12">Gessner et al., 2000</xref>), can form around the positively charged NPs. This protein corona acts as a steric barrier, reducing close contact with the plasma membrane and, in turn, the likelihood of endocytosis (<xref ref-type="bibr" rid="B11">Forest and Pourchez, 2017</xref>; <xref ref-type="bibr" rid="B3">Bashiri et al., 2023</xref>; <xref ref-type="bibr" rid="B20">Lesniak et al., 2013</xref>). The observed charge inversion in the medium highlights the complex interplay between NP surface properties and the biological environment, which governs NP-cell interactions. Despite this charge reversal, we classify AuNR(&#x2b;) as positively charged to reflect their intrinsic surface properties in water and to maintain consistency with the convention used in the literature. The increased internalization of AuNR&#xd8; in 2D monolayers can be attributed to NP aggregation, which occurs more easily due to their lower colloidal stability (<xref ref-type="bibr" rid="B19">Keller et al., 2010</xref>; <xref ref-type="bibr" rid="B26">Moore et al., 2019</xref>). NP aggregates are more readily taken up by the cells, as their larger size promotes sedimentation and increased interactions with the cell membrane (<xref ref-type="bibr" rid="B4">Behzadi et al., 2017</xref>). In spheroids, however, no large aggregates were detected and AuNR&#xd8; showed the lowest accumulation.</p>
<p>Analysis of spheroid penetration revealed similar penetration curves for AuNR(&#x2212;), AuNR&#xd8;, and AuNR(&#x2b;). However, confocal microscopy images consistently showed that a small fraction of AuNR(&#x2212;) reached deeper layers compared to the other NPs. This enhanced penetration of AuNR(&#x2212;) is likely due to electrostatic repulsion with the negatively charged ECM, which facilitates diffusion (<xref ref-type="bibr" rid="B16">Huang et al., 2017</xref>). Although AuNR(&#x2b;) acquired a negative charge in the medium, its protein corona likely restricted its movement, keeping it concentrated at the spheroid&#x2019;s periphery (<xref ref-type="bibr" rid="B16">Huang et al., 2017</xref>). AuNR&#xd8;, while preventing strong interactions, are hindered by their tendency to form bigger aggregates causing steric hindrance within the tumor structure. These findings underscore the efficient internalization and superior spheroid penetration of negatively charged NPs and spotlight the importance of surface charge in the design of NPs for cancer therapy.</p>
</sec>
<sec id="s7">
<title>Effect of nanoparticle shape</title>
<p>The shape of NPs affects their internalization in both 2D and 3D models. In our study, spherical AuNS50 and AuNS10 exhibit higher uptake compared to rod-shaped AuNR(&#x2212;) in both 2D and 3D models. This difference is likely due to the higher energy barrier faced by rod-shaped NPs for cellular internalization, as membrane wrapping is less efficient (<xref ref-type="bibr" rid="B21">Li et al., 2015</xref>). Additionally, rod-shaped NPs can enter cells at various angles, which also impacts their uptake rate (<xref ref-type="bibr" rid="B21">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Xie et al., 2017</xref>).</p>
<p>In the spheroid model, spherical NPs showed deeper penetration than rod-shaped NPs, probably due to differences in interactions of each shape with the dense ECM network (<xref ref-type="bibr" rid="B1">Agarwal et al., 2015</xref>). Rod-shaped NPs encounter greater steric hindrance due to their elongated form, making it harder to navigate through tight spaces and limiting their diffusion in spheroids. Spherical NPs, on the other hand, reach deeper layers, with the occasional detection of AuNS50 in the spheroid core. Of note, when lower concentration was used, this core fraction was not detected due to reduced NP accumulation (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>In conclusion, this research highlights the value of 3D spheroid models in better understanding NP interactions, offering insights not visible in 2D monolayers. Our results revealed key differences between the two models: while 2D models provide a preliminary understanding of NP internalization, they often do not correlate with <italic>in vivo</italic> behaviour. Spheroids, on the other hand, enabled us to observe the interplay between NP and cells within the tumor, which drives internalization, and NP-ECM interactions, which govern deeper penetration. By leveraging advanced 3D <italic>in vitro</italic> models, researchers can achieve a more comprehensive characterization of NP behaviour, providing more reliable data that can bridge the gap between preclinical findings and clinical outcomes. This research is not intended to establish a generalized set of NP properties or serve as a comprehensive guide for therapeutic evaluation. Instead, it provides a framework for understanding how NP size, shape and surface charge influence their behavior in spheroid models. By using a robust methodological approach that integrates 2D and 3D models, two-photon fluorescence microscopy and a custom algorithm, this study provides well-controlled analyses that clarify conflicting findings reported on this topic. Of note, these findings are not universally applicable to other types of NPs as differences in other physicochemical properties - such as stiffness, stability, and hydrophobicity - can significantly influence their interactions with cells, internalization mechanisms, and penetration behavior. Future investigations are needed to validate these behaviors across diverse nanoparticle platforms, particularly in 3D models that better mimic the tumor environment. This approach holds promise for developing optimized nanomaterials with improved performance and a higher likelihood of clinical success in cancer therapy.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s8">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s9">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by KU Leuven (S65960) for the use of commercially available established cell lines. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s10">
<title>Author contributions</title>
<p>PC: Data curation, Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing&#x2013;original draft, Writing&#x2013;review and editing. MB: Data curation, Investigation, Methodology, Validation, Writing&#x2013;review and editing. JJ-KC: Methodology, Writing&#x2013;review and editing. IV: Supervision, Writing&#x2013;review and editing. SK: Investigation, Methodology, Writing&#x2013;review and editing. FT: Investigation, Supervision, Writing&#x2013;review and editing. HU-i: Funding acquisition, Project administration, Supervision, Writing&#x2013;review and editing. JH: Funding acquisition, Project administration, Supervision, Writing&#x2013;review and editing. SR: Conceptualization, Funding acquisition, Project administration, Software, Supervision, Writing&#x2013;review and editing. BF: Conceptualization, Data curation, Formal Analysis, Investigation, Supervision, Validation, Visualization, Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s11">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project has received funding from the European Union&#x2019;s Horizon 2020 research and innovation program under the Marie Sk&#x142;odowska-Curie grant agreement no. 860914. We acknowledge additional financial support from Research Foundation of Flanders (FWO) research grants (G0D4519N, G081916N, VS08523N, G0C1821N, and G022724N), postdoctoral fellowships (for BF: 12X1419N and 12X1423N, for IV: 12A6N25N), and from the KU Leuven (IDN/20/021, C14/15/053, C14/19/079, and C14/22/085). MB acknowledges the Global PhD partnership program between KU Leuven and Melbourne university (GPUM/21/025).</p>
</sec>
<sec sec-type="COI-statement" id="s12">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s13">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s14">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s15">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2024.1520078/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2024.1520078/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jurney</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Raythatha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sreenivasan</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models</article-title>. <source>Adv. Healthc. Mater</source> <volume>4</volume>, <fpage>2269</fpage>&#x2013;<lpage>2280</lpage>. <pub-id pub-id-type="doi">10.1002/adhm.201500441</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barua</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mitragotri</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects</article-title>. <source>Nano Today</source> <volume>23</volume>, <fpage>223</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.nantod.2014.04.008</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bashiri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Padilla</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Swingle</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Nanoparticle protein corona: from structure and function to therapeutic targeting</article-title>. <source>Lab. Chip</source> <volume>23</volume>, <fpage>1432</fpage>&#x2013;<lpage>1466</lpage>. <pub-id pub-id-type="doi">10.1039/d2lc00799a</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behzadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Serpooshan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hamaly</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Alkawareek</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Dreaden</surname>
<given-names>E. C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Cellular uptake of nanoparticles: journey inside the cell</article-title>. <source>Chem. Soc. Rev.</source> <volume>46</volume>, <fpage>4218</fpage>&#x2013;<lpage>4244</lpage>. <pub-id pub-id-type="doi">10.1039/c6cs00636a</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biju</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Priya</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review</article-title>. <source>Drug Deliv. Transl. Res.</source> <volume>13</volume>, <fpage>2239</fpage>&#x2013;<lpage>2253</lpage>. <pub-id pub-id-type="doi">10.1007/s13346-023-01327-6</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fortuni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mulvaney</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hofkens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Uji-I</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Nanoparticle-mediated thermal Cancer therapies: strategies to improve clinical translatability</article-title>. <source>J. Control. Release</source> <volume>372</volume>, <fpage>751</fpage>&#x2013;<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2024.06.055</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Centurion</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Size-dependent penetration of nanoparticles in tumor spheroids: a multidimensional and quantitative study of transcellular and paracellular pathways</article-title>. <source>Small</source> <volume>20</volume>, <fpage>2304693</fpage>. <pub-id pub-id-type="doi">10.1002/smll.202304693</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kankala</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation</article-title>. <source>Coord. Chem. Rev.</source> <volume>481</volume>, <fpage>215051</fpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2023.215051</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dreaden</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Alkilany</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The golden age: gold nanoparticles for biomedicine</article-title>. <source>Chem. Soc. Rev.</source> <volume>41</volume>, <fpage>2740</fpage>&#x2013;<lpage>2779</lpage>. <pub-id pub-id-type="doi">10.1039/c1cs15237h</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Nanomedicine in cancer therapy</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>8</volume>, <fpage>293</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01536-y</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forest</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pourchez</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: a too simplistic explanation that does not take into account the nanoparticle protein corona</article-title>. <source>Mater. Sci. Eng. C</source> <volume>70</volume>, <fpage>889</fpage>&#x2013;<lpage>896</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2016.09.016</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gessner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Waicz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lieske</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paulke</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>M&#xe4;der</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>R. H.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption</article-title>. <source>Int. J. Pharm.</source> <volume>196</volume>, <fpage>245</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1016/s0378-5173(99)00432-9</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf6;rlach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Acker</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1227</volume>, <fpage>105</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/0925-4439(94)90085-x</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Morin</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwendeman</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Survey of clinical translation of cancer nanomedicines - lessons learned from successes and failures</article-title>. <source>Acc. Chem. Res.</source> <volume>52</volume>, <fpage>2445</fpage>&#x2013;<lpage>2461</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.9b00228</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshyar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The effect of nanoparticle size on <italic>in vivo</italic> pharmacokinetics and cellular interaction</article-title>. <source>Nanomedicine</source> <volume>11</volume>, <fpage>673</fpage>&#x2013;<lpage>692</lpage>. <pub-id pub-id-type="doi">10.2217/nnm.16.5</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Boerhan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Nanoparticles penetrate into the multicellular spheroid-on-chip: effect of surface charge, protein corona, and exterior flow</article-title>. <source>Mol. Pharm.</source> <volume>14</volume>, <fpage>4618</fpage>&#x2013;<lpage>4627</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.7b00726</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors <italic>in vivo</italic>
</article-title>. <source>ACS Nano</source> <volume>6</volume>, <fpage>4483</fpage>&#x2013;<lpage>4493</lpage>. <pub-id pub-id-type="doi">10.1021/nn301282m</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy</article-title>. <source>J. Adv. Res.</source> <volume>1</volume>, <fpage>13</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2010.02.002</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lenihan</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Cherr</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cardinale</surname>
<given-names>B. J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Stability and aggregation of metal oxide nanoparticles in natural aqueous matrices</article-title>. <source>Environ. Sci. Technol.</source> <volume>44</volume>, <fpage>1962</fpage>&#x2013;<lpage>1967</lpage>. <pub-id pub-id-type="doi">10.1021/es902987d</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesniak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salvati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santos-Martinez</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Radomski</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>&#xc5;berg</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume>, <fpage>1438</fpage>&#x2013;<lpage>1444</lpage>. <pub-id pub-id-type="doi">10.1021/ja309812z</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kr&#xf6;ger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W. K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Shape effect in cellular uptake of PEGylated nanopar-ticles: comparison between sphere, rod, cube and disk</article-title>. <source>Nanoscale</source> <volume>7</volume>, <fpage>16631</fpage>&#x2013;<lpage>16646</lpage>. <pub-id pub-id-type="doi">10.1039/C5NR02970H</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Link</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Erratum: simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant (Journal of Physical Chemistry B (1999) 103B)</article-title>. <source>J. Phys. Chem. B</source> <volume>109</volume>, <fpage>10531</fpage>&#x2013;<lpage>10532</lpage>. <pub-id pub-id-type="doi">10.1021/jp058091f</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lunnoo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Assawakhajornsak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Puangmali</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>In silico</italic> study of gold nanoparticle uptake into a mammalian cell: interplay of size, shape, surface charge, and aggregation</article-title>. <source>J. Phys. Chem. C</source> <volume>123</volume>, <fpage>3801</fpage>&#x2013;<lpage>3810</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcc.8b07616</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Influence of nanoparticle shape, size, and surface functionalization on cellular uptake</article-title>. <source>J. Nanosci. Nanotechnol.</source> <volume>13</volume>, <fpage>6485</fpage>&#x2013;<lpage>6498</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2013.7525</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Poole</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Goyette</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gaus</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Introducing membrane charge and membrane potential to T cell signaling</article-title>. <source>Front. Immunol.</source> <volume>8</volume>, <fpage>1513</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01513</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Rodriguez-Lorenzo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Milosevic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crippa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Spuch-Calvar</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Nanoparticle administration method in cell culture alters particle-cell interaction</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>900</fpage>&#x2013;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-36954-4</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olesiak-Banska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waszkielewicz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Obstarczyk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Samoc</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Two-photon absorption and photoluminescence of colloidal gold nanoparticles and nanoclusters</article-title>. <source>Chem. Soc. Rev.</source> <volume>48</volume>, <fpage>4087</fpage>&#x2013;<lpage>4117</lpage>. <pub-id pub-id-type="doi">10.1039/c8cs00849c</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pratiwi</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Tung</surname>
<given-names>Y. C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Evaluation of nanoparticle penetration in the tumor spheroid using two-photon microscopy</article-title>. <source>Biomedicines</source> <volume>9</volume>, <fpage>10</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3390/biomedicines9010010</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salatin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maleki Dizaj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yari Khosroushahi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effect of the surface modification, size, and shape on cellular uptake of nanoparticles</article-title>. <source>Cell Biol. Int.</source> <volume>39</volume>, <fpage>881</fpage>&#x2013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1002/cbin.10459</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nienhaus</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ulrich Nienhaus</surname>
<given-names>G.</given-names>
</name>
</person-group> <article-title>Engineered nanoparticles interacting with cells: size matters. <italic>Nanobiotechnology</italic> 12</article-title>, (<year>2014</year>).</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Sureka</surname>
<given-names>H. V.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>C. K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Membrane potential mediates the cellular binding of nanoparticles</article-title>. <source>Nanoscale</source> <volume>5</volume>, <fpage>5879</fpage>&#x2013;<lpage>5886</lpage>. <pub-id pub-id-type="doi">10.1039/c3nr01667f</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sujai</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Saranya</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Murali</surname>
<given-names>V. P.</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>K. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Surface charge modulates the internalization: vs. penetration of gold nanoparticles: comprehensive scrutiny on monolayer cancer cells, multicellular spheroids and solid tumors by SERS modality</article-title>. <source>Nanoscale</source> <volume>12</volume>, <fpage>6971</fpage>&#x2013;<lpage>6975</lpage>. <pub-id pub-id-type="doi">10.1039/d0nr00809e</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tchoryk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taresco</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Argent</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Ashford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gellert</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Stolnik</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Penetration and uptake of nanoparticles in 3D tumor spheroids</article-title>. <source>Bioconjug Chem.</source> <volume>30</volume>, <fpage>1371</fpage>&#x2013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1021/acs.bioconjchem.9b00136</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Zundert</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fortuni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>From 2d to 3d cancer cell models&#x2014;the enigmas of drug delivery research</article-title>. <source>Nanomaterials</source> <volume>10</volume>, <fpage>2236</fpage>. <pub-id pub-id-type="doi">10.3390/nano10112236</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Zundert</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Maenhoudt</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>De Vriendt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vankelecom</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fortuni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Fluorescence imaging of 3D cell models with subcellular resolution</article-title>. <source>Bio Protoc.</source> <volume>12</volume>, <fpage>e4469</fpage>. <pub-id pub-id-type="doi">10.21769/BioProtoc.4469</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H. X.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z. Q.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z. T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines</article-title>. <source>Nano Today</source> <volume>11</volume>, <fpage>133</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.nantod.2016.04.008</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="web">
<collab>WHO</collab> (<year>2022</year>). <article-title>Cancer - world health organization</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/cancer">https://www.who.int/news-room/fact-sheets/detail/cancer</ext-link>.</comment>
</citation>
</ref>
<ref id="B38">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wriedt</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2012</year>). &#x201c;<article-title>The mie theory: a review</article-title>,&#x201d; in <source>
<italic>The mie theory: Basics and applications</italic> 53&#x2013;71</source>. <pub-id pub-id-type="doi">10.1007/978-3-642-28738-1</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The effect of shape on cellular uptake of gold nanoparticles in the forms of stars, rods, and triangles</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>3827</fpage>&#x2013;<lpage>3829</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-04229-z</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yetisgin</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Cetinel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zuvin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kosar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kutlu</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Therapeutic nanoparticles and their targeted delivery applications</article-title>. <source>Molecules</source> <volume>25</volume>, <fpage>2193</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25092193</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Shape effect of nanoparticles on tumor penetration in monolayers versus spheroids</article-title>. <source>Mol. Pharm.</source> <volume>16</volume>, <fpage>2902</fpage>&#x2013;<lpage>2911</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.9b00107</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stenzel</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Influence of nanoparticle shapes on cellular uptake of paclitaxel loaded nanoparticles in 2D and 3D cancer models</article-title>. <source>Polym. Chem.</source> <volume>8</volume>, <fpage>3317</fpage>&#x2013;<lpage>3326</lpage>. <pub-id pub-id-type="doi">10.1039/c7py00385d</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>